Insulet
PODD
#1042
Rank
S$24.95 B
Marketcap
$355.71
Share price
-0.81%
Change (1 day)
27.27%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $2.33

According to Insulet's latest financial reports the company's current EPS (TTM) is $2.32. In 2022 the company made an earnings per share (EPS) of $0.09455 a decrease over its 2021 EPS that were of $0.31.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.332360.6%
2022$0.09455-69.57%
2021$0.31109.09%
2020$0.15-38.89%
2019$0.24200%
2018$0.08104-113.04%
2017-$0.62-9.8%
2016-$0.69-60.77%
2015-$1.7639.78%
2014-$1.2612.05%
2013-$1.12-23.15%
2012-$1.4610.2%
2011-$1.32-36.36%
2010-$2.08-36.63%
2009-$3.28-29.36%
2008-$4.65-86.74%
2007-$35.04-64.04%
2006-$97.45122.23%
2005-$43.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.73-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.36-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.32-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.03 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.01 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.67 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$7.33 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA